Arginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates
- PMID: 29720452
- PMCID: PMC6714978
- DOI: 10.1126/scitranslmed.aam9100
Arginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by core social impairments. ASD remains poorly understood because of the difficulty in studying disease biology directly in patients and the reliance on mouse models that lack clinically relevant, complex social cognition abilities. We use ethological observations in rhesus macaques to identify male monkeys with naturally occurring low sociality. These monkeys showed differences in specific neuropeptide and kinase signaling pathways compared to socially competent male monkeys. Using a discovery and replication design, we identified arginine vasopressin (AVP) in cerebrospinal fluid (CSF) as a key marker of group differences in monkey sociality; we replicated these findings in an independent monkey cohort. We also confirmed in an additional monkey cohort that AVP concentration in CSF is a stable trait-like measure. Next, we showed in a small pediatric cohort that CSF AVP concentrations were lower in male children with ASD compared to age-matched male children without ASD (but with other medical conditions). We demonstrated that CSF AVP concentration was sufficient to accurately distinguish ASD cases from medical controls. These data suggest that AVP and its signaling pathway warrant consideration in future research studies investigating new targets for diagnostics and drug development in ASD.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Figures
References
-
- American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, ed. 5, 2013).
-
- Christensen DL, Baio J, Van Naarden Braun K, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Lee L-C, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate MS, Zahorodny W, Yeargin-Allsopp M, Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill. Summ 65, 1–23 (2016). - PMC - PubMed
-
- Buescher AVS, Cidav Z, Knapp M, Mandell DS, Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr. 168, 721–728 (2014). - PubMed
-
- Garner JP, Gaskill BN, Weber EM, Ahloy-Dallaire J, Pritchett-Corning KR, Introducing therioepistemology: The study of how knowledge is gained from animal research. Lab Anim. 46, 103–113 (2017). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
